With the synthesis of 3a, to a 10 mL Schlenk tube under air conditions, Ni(NTf2)2 (10 mol%, 3.1 mg), L1 (15 mol%) and MTBE (1.5 mL) were added, and the mixture was stirred for 1 h at room temperature. Then, 1a (0.05 mmol, 1.0 equiv.) and 2a (0.075 mmol, 1.5 equiv.) were successively added. The mixture was stirred at room temperature about 2 d. After the reaction was completed [indicated by thin-layer chromatography (TLC), petroleum ether/EtOAc, V∶V=5∶1], the reaction mixture was concentrated by vacuum distillation and purified by flash column chromatography (petroleum ether/acetone, V∶V=20∶1) to afford the desired pure product 3a as a yellow solid. Compunds 3b~3y were synthesized with the same method.
Isopropyl (R,E)-10-phenyl-10,15-dihydro-9H-naphtho-[2',1':2,3]azocino[4,5-b]indole-8-carboxylate (3a): Yellow solid, 15.6 mg, 70% yield. ${[\alpha ]}_{\text{D}}^{\text{20}}$-23.0 (c 0.3, acetone). m.p. 185~186 ℃; 1H NMR (400 MHz, CDCl3) δ: 8.08 (s, 1H), 7.98~7.84 (m, 3H), 7.58~7.49 (m, 2H), 7.47 (d, J=8.0 Hz, 1H), 7.39 (d, J=8.0 Hz, 1H), 7.31 (d, J=8.0 Hz, 1H), 7.24~7.17 (m, 3H), 7.14 (t, J=8.0 Hz, 2H), 7.11~7.02 (m, 2H), 5.32~5.15 (m, 1H), 5.07~4.90 (m, 1H), 3.35~3.20 (m, 1H), 2.92 (t, J=12.0 Hz, 1H), 1.42 (d, J=8.0 Hz, 3H), 1.35 (d, J=8.0 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ: 163.9, 163.2, 146.6, 144.3, 135.9, 133.5, 129.8, 129.0, 128.7, 128.6, 127.8, 127.5, 127.4, 126.6, 126.5, 125.6, 122.9, 121.6, 119.8, 119.2, 117.7, 117.6, 110.6, 70.3, 40.8, 38.1, 21.9, 21.9; HRMS (ESI) calcd for C31H27N2O2 (M+H)+ 495.2067, found 495.2066. HPLC analysis: 90∶10 er [Daicel Chiralpak IA, hexane/i-PrOH, V∶V=60∶40, 0.8 mL/min, λ=254 nm, tR(minor)=7.7 min, tR(major)=24.7 min].
Isopropyl (R,E)-12-methyl-10-phenyl-10,15-dihydro-9H-naphtho[2',1':2,3]azocino[4,5-b]indole-8-carboxylate (3b): Yellow solid, 14.8 mg, 63% yield. ${[\alpha ]}_{\text{D}}^{\text{20}}$ +161.5 (c 0.5, acetone). m.p. 207~208 ℃; 1H NMR (400 MHz, CDCl3) δ: 8.00~7.85 (m, 4H), 7.56~7.47 (m, 2H), 7.38 (d, J=8.0 Hz, 1H), 7.25~7.18 (m, 4H), 7.15 (t, J=8.0 Hz, 2H), 7.11~7.05 (m, 1H), 7.02 (d, J=8.0 Hz, 1H), 5.28~5.16 (m, 1H), 5.07~4.92 (m, 1H), 3.29~3.20 (m, 1H), 2.89 (t, J=12.0 Hz, 1H), 2.39 (s, 3H), 1.43 (d, J=4.0 Hz, 3H), 1.36 (d, J=4.0 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ: 163.7, 163.2, 146.4, 144.4, 134.1, 133.4, 132.0, 129.6, 129.1, 129.0, 128.6, 128.5, 127.9, 127.4, 127.3, 126.5, 125.5, 124.5, 121.5, 118.7, 117.7, 117.1, 110.2, 70.3, 40.6, 38.2, 21.9, 21.8, 21.6; HRMS (ESI) calcd for C32H29N2O2 (M+H)+ 473.2224, found 473.2220. HPLC analysis: 86∶14 er [Daicel Chiralpak IA, hexane/i-PrOH, V∶V=60∶40, 0.8 mL/min, λ=254 nm, tR(minor)=4.5 min, tR(major)=4.2 min].
Isopropyl (R,E)-13-methyl-10-phenyl-10,15-dihydro-9H-naphtho[2',1':2,3]azocino[4,5-b]indole-8-carboxylate (3c): Yellow solid, 16.5 mg, 66% yield. ${[\alpha ]}_{\text{D}}^{\text{20}}$ -67.0 (c 0.1, acetone). m.p. 205~207 ℃; 1H NMR (400 MHz, CDCl3) δ: 7.96~7.89 (m, 3H), 7.56~7.48 (m, 2H), 7.39 (d, J=8.0 Hz, 1H), 7.33 (d, J=8.0 Hz, 1H), 7.28~7.26 (m, 1H), 7.23~7.18 (m, 2H), 7.17~7.10 (m, 3H), 7.10~7.03 (m, 1H), 6.89 (d, J=8.0 Hz, 1H), 5.27~5.17 (m, 1H), 5.02~4.93 (m, 1H), 3.32~3.20 (m, 1H), 2.89 (t, J=12.0 Hz, 1H), 2.44 (s, 3H), 1.42 (d, J=6.0 Hz, 3H), 1.36 (d, J=6.1 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ: 163.7, 163.2, 146.4, 144.3, 136.2, 133.4, 132.9, 132.0, 129.6, 128.8, 128.6, 128.5, 128.3, 127.4, 127.3, 127.1, 126.5, 125.5, 121.6, 121.4, 118.8, 117.7, 117.5, 110.4, 70.3, 40.7, 38.0, 21.9, 21.8, 21.8; HRMS (ESI) calcd for C32H29N2O2 (M+H)+ 473.2224, found 473.2221. HPLC analysis: 88∶12 er [Daicel Chiralpak OD-H, hexane/i-PrOH, V∶V=70∶30, 1 mL/min, λ=254 nm, tR(minor)=5.1 min, tR(major)=4.1 min].
Cyclopentyl (R,E)-10-(4-chlorophenyl)-10,15-dihydro-9H-naphtho[2',1':2,3]azocino[4,5-b]indole-8-carboxylate (3d): Yellow solid, 15.3 mg, 59% yield. ${[\alpha ]}_{\text{D}}^{\text{20}}$ -41.4 (c 0.3, acetone). m.p. 211~212 ℃; 1H NMR (400 MHz, CDCl3) δ: 7.80~7.65 (m, 4H), 7.50 (t, J=8.0 Hz, 2H), 7.42 (t, J=8.0 Hz, 1H), 7.36~7.29 (m, 3H), 7.25~7.22 (m, 1H), 7.19~7.08 (m, 4H), 7.05 (t, J=8.0 Hz, 1H), 5.43~5.31 (m, 1H), 5.01~4.91 (m, 1H), 3.58 (s, 3H), 3.25~3.11 (m, 1H), 2.84 (t, J=12.0 Hz, 1H), 2.09~1.65 (m, 8H); 13C NMR (100 MHz, CDCl3) δ: 163.3, 163.3, 146.5, 142.7, 135.7, 133.3, 132.2, 132.0, 129.9, 129.0, 128.8, 128.7, 128.6, 127.5, 127.5, 126.2, 125.7, 123.1, 121.5, 119.9, 118.8, 117.2, 117.1, 110.6, 40.1, 37.9, 32.8, 32.6, 23.9, 23.9; HRMS (ESI) calcd for C33H28ClN2O2 (M+H)+ 519.1834, found 519.1833. HPLC analysis: 95∶5 er [Daicel Chiralpak IA, hexane/i-PrOH, V∶V=60∶40, 0.8 mL/min, λ=254 nm, tR(minor)=4.8 min, tR(major)=4.2 min].
Isopropyl (R,E)-13-methyl-8-phenyl-8,13-dihydro-7H-benzo[2,3]azocino[4,5-b]indole-6-carboxylate (3e): Yellow solid, 15.8 mg, 73% yield. ${[\alpha ]}_{\text{D}}^{\text{20}}$ -35.8 (c 1.2, acetone). m.p. 192~193 ℃; 1H NMR (400 MHz, CDCl3) δ: 7.53~7.45 (m, 2H), 7.44~7.35 (m, 2H), 7.31 (d, J=8.0 Hz, 1H), 7.27~7.17 (m, 6H), 7.16~7.09 (m, 1H), 7.05 (t, J=8.0 Hz, 1H), 5.28~5.18 (m, 1H), 5.05~4.95 (m, 1H), 3.52 (s, 3H), 3.30~3.21 (m, 1H), 2.84 (t, J=12.0 Hz, 1H), 1.43 (d, J=8.0 Hz, 3H), 1.39 (d, J=8.0 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ: 164.0, 163.2, 149.0, 145.0, 137.8, 133.7, 132.1, 129.0, 128.7, 127.3, 127.1, 126.6, 125.2, 122.5, 122.1, 121.7, 119.6, 119.1, 115.8, 109.4, 70.3, 41.1, 38.6, 31.2, 21.9; HRMS (ESI) calcd for C28H27N2O2 (M+H)+ 423.2067, found 423.2062. HPLC analysis: 87∶13 er [Daicel Chiralpak IA, hexane/i-PrOH, V∶V=99∶1, 1 mL/ min, λ=254 nm, tR(minor)=32.2 min, tR(major)=44.9 min].
Cyclopentyl (R,E)-13-methyl-8-phenyl-8,13-dihydro-7H-benzo[2,3]azocino[4,5-b]indole-6-carboxylate (3f): Yellow solid, 20.3 mg, 71% yield. ${[\alpha ]}_{\text{D}}^{\text{20}}$ +29.3 (c 0.4, acetone). m.p. 220~222 ℃; 1H NMR (400 MHz, CDCl3) δ: 7.48 (t, J=8.0 Hz, 2H), 7.40~7.33 (m, 2H), 7.29 (t, J=8.0 Hz, 1H), 7.25~7.14 (m, 6H), 7.14~7.08 (m, 1H), 7.03 (t, J=8.0 Hz, 1H), 5.42~5.31 (m, 1H), 5.00~4.91 (m, 1H), 3.51 (s, 3H), 3.23~3.13 (m, 1H), 2.82 (t, J=12.0 Hz, 1H), 2.03~1.92 (m, 2H), 1.91~1.59 (m, 6H); 13C NMR (100 MHz, CDCl3) δ: 164.0, 163.4, 149.0, 144.9, 137.8, 133.6, 132.1, 129.0, 128.7, 127.3, 127.0, 126.6, 125.1, 122.5, 122.0, 121.7, 119.6, 119.0, 115.7, 109.4, 79.4, 41.1, 38.7, 32.9, 32.6, 31.2, 24.0, 23.9; HRMS (ESI) calcd for C30H29N2O2 (M+H)+ 449.2224, found 449.2220. HPLC analysis: 90∶10 er [Daicel Chiralpak IA, hexane/i-PrOH, V∶V=60∶40, 0.7 mL/min, λ=254 nm, tR(minor)=8.9 min, tR(major)=9.6 min].
Cyclohexyl (R,E)-13-methyl-8-phenyl-8,13-dihydro-7H-benzo[2,3]azocino[4,5-b]indole-6-carboxylate (3g): Yellow solid, 20.9 mg, 71% yield. ${[\alpha ]}_{\text{D}}^{\text{20}}$ -38.1 (c 0.2, acetone). m.p. 220~222 ℃; 1H NMR (400 MHz, CDCl3) δ: 7.49 (d, J=8.0 Hz, 2H), 7.41~7.34 (m, 2H), 7.30 (d, J=8.0 Hz, 1H), 7.27~7.16 (m, 6H), 7.16~7.09 (m, 1H), 7.04 (t, J=8.0 Hz, 1H), 5.07~4.93 (m, 2H), 3.51 (s, 3H), 3.29~3.16 (m, 1H), 2.85 (t, J=12.0 Hz, 1H), 2.04~1.93 (m, 2H), 1.89~1.76 (m, 2H), 1.73~1.32 (m, 6H); 13C NMR (100 MHz, CDCl3) δ: 164.0, 162.9, 148.9, 144.9, 137.7, 133.6, 132.0, 129.0, 128.6, 127.3, 127.0, 126.5, 125.1, 122.4, 122.0, 121.6, 119.5, 119.0, 115.7, 109.4, 75.1, 41.1, 38.7, 31.5, 31.5, 31.1, 25.4, 23.9; HRMS (ESI) calcd for C31H31N2O2 (M+H)+ 463.2380, found 463.2378. HPLC analysis: 86∶14 er [Daicel Chiralpak IA, hexane/i-PrOH, V∶V=60∶40, 0.7 mL/min, λ=254 nm, tR(minor)=9.0 min, tR(major)=10.9 min].
Cyclopentyl (R,E)-13-ethyl-8-phenyl-8,13-dihydro-7H-benzo[2,3]azocino[4,5-b]indole-6-carboxylate (3h): Yellow solid, 16.1 mg, 70% yield. ${[\alpha ]}_{\text{D}}^{\text{20}}$ -116.8 (c 0.9, acetone). m.p. 149~150 ℃; 1H NMR (400 MHz, CDCl3) δ: 7.54 (d, J=8.0 Hz, 1H), 7.48 (t, J=8.0 Hz, 1H), 7.43~7.31 (m, 3H), 7.25~7.15 (m, 6H), 7.15~7.09 (m, 1H), 7.04 (t, J=8.0 Hz, 1H), 5.41~5.31 (m, 1H), 5.02~4.90 (m, 1H), 4.07~3.94 (m, 2H), 3.23~3.11 (m, 1H), 2.82 (t, J=12.0 Hz, 1H), 2.03~1.93 (m, 2H), 1.93~1.66 (m, 6H), 1.16 (t, J=4.0 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ: 164.1, 163.2, 149.0, 144.8, 136.8, 133.2, 131.6, 129.0, 128.6, 127.4, 127.3, 126.5, 125.1, 122.3, 121.9, 119.5, 119.0, 116.0, 109.8, 79.3, 41.1, 38.8, 38.7, 32.9, 32.6, 23.9, 23.9, 15.2; HRMS (ESI) calcd for C31H31N2O2 (M+H)+ 463.2380, found 463.2377. HPLC analysis: 86∶14 er [Daicel Chiralpak OD-H, hexane/i-PrOH, V∶V=50∶50, 0.8 mL/min, λ=254 nm, tR(minor)=5.8 min, tR(major)=5.2 min].
Cyclopentyl (R,E)-2-bromo-13-methyl-8-phenyl-8,13-dihydro-7H-benzo[2,3]azocino[4,5-b]indole-6-carboxylate (3i): Yellow solid, 18.9 mg, 72% yield. ${[\alpha ]}_{\text{D}}^{\text{20}}$ -116.0 (c 1.7, acetone). m.p. 195~196 ℃; 1H NMR (400 MHz, CDCl3) δ: 7.66 (s, 1H), 7.59 (d, J=8.0 Hz, 1H), 7.37 (d, J=8.0 Hz, 1H), 7.33~7.28 (m, 1H), 7.27~7.20 (m, 3H), 7.17~7.11 (m, 3H), 7.05 (t, J=8.0 Hz, 1H), 5.44~5.30 (m, 1H), 5.03~4.93 (m, 1H), 3.54 (s, 3H), 3.27~3.17 (m, 1H), 2.81 (t, J=12.0 Hz, 1H), 2.07~1.65 (m, 8H); 13C NMR (100 MHz, CDCl3) δ: 164.4, 163.1, 147.9, 144.5, 137.9, 134.4, 132.1, 132.0, 128.7, 127.2, 126.9, 126.7, 123.8, 123.7, 122.9, 119.8, 119.2, 118.2, 116.4, 109.5, 79.5, 41.0, 38.6, 32.9, 32.6, 31.3, 23.9, 23.9; HRMS (ESI) calcd for C30H28BrN2O2 (M+H)+ 527.1329, found 527.1328. HPLC analysis: 91∶9 er [Daicel Chiralpak IA, hexane/i-PrOH, V∶V=60∶40, 0.9 mL/min, λ=254 nm, tR(minor)=6.1 min, tR(major)=8.0 min].
Cyclopentyl (R,E)-2-methoxy-13-methyl-8-phenyl-8,13-dihydro-7H-benzo[2,3]azocino[4,5-b]indole-6-carboxylate (3j): Yellow solid, 14.5 mg, 61% yield. ${[\alpha ]}_{\text{D}}^{\text{20}}$ +40.4 (c 1.3, acetone). m.p. 170~171 ℃; 1H NMR (400 MHz, CDCl3) δ: 7.36 (d, J=8.0 Hz, 1H), 7.30~7.26 (m, 1H), 7.24~7.15 (m, 6H), 7.14~7.08 (m, 1H), 7.07~6.98 (m, 3H), 5.35 (s, 1H), 4.98~4.89 (m, 1H), 3.90 (s, 3H), 3.51 (s, 3H), 3.19~3.11 (m, 1H), 2.85 (t, J=12.0 Hz, 1H), 2.04~1.92 (m, 2H), 1.90~1.62 (m, 6H); 13C NMR (100 MHz, CDCl3) δ: 163.8, 163.5, 157.0, 144.9, 142.5, 137.9, 133.6, 128.7, 127.3, 127.0, 126.6, 123.6, 122.8, 122.6, 119.6, 119.1, 117.1, 115.9, 114.7, 109.4, 79.3, 55.7, 41.0, 38.6, 32.9, 32.6, 31.3, 24.0, 23.9; HRMS (ESI) calcd for C31H31N2O3 (M+H)+ 479.2329, found 479.2328. HPLC analysis: 84∶16 er [Daicel Chiralpak IA, hexane/i-PrOH, V∶V=60∶40, 0.7 mL/min, λ=254 nm, tR(minor)=7.5 min, tR(major)=8.7 min].
Isopropyl (R,E)-13-methyl-3,8-diphenyl-8,13-dihydro-7H-benzo[2,3]azocino[4,5-b]indole-6-carboxylate (3k): Yellow solid, 17.4 mg, 70% yield. ${[\alpha ]}_{\text{D}}^{\text{20}}$ -210.5 (c 0.6, acetone). m.p. 197~198 ℃; 1H NMR (400 MHz, CDCl3) δ: 7.80~7.70 (m, 4H), 7.54 (t, J=8.0 Hz, 2H), 7.44 (d, J=8.0 Hz, 2H), 7.38~7.32 (m, 2H), 7.29~7.21 (m, 5H), 7.19~7.11 (m, 1H), 7.08 (t, J=8.0 Hz, 1H), 5.36~5.21 (m, 1H), 5.13~4.98 (m, 1H), 3.61 (s, 3H), 3.38~3.24 (m, 1H), 2.94 (t, J=12.0 Hz, 1H), 1.46 (d, J=4.0 Hz, 3H), 1.42 (d, J=4.0 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ: 164.1, 163.2, 148.1, 144.9, 140.0, 138.0, 137.9, 133.6, 130.4, 129.1, 128.7, 127.8, 127.7, 127.3, 127.0, 126.6, 122.7, 122.6, 122.2, 119.6, 119.2, 116.0, 109.5, 70.4, 41.1, 38.6, 31.3, 21.9, 21.9; HRMS (ESI) calcd for C34H31N2O2 (M+H)+: 499.2380, found 499.2378. HPLC analysis: 87∶13 er [Daicel Chiralpak OD-H, hexane/i-PrOH, V∶V=50/50, 0.8 mL/min, λ=254 nm, tR(minor)=6.9 min, tR(major)=5.6 min].
Cyclopentyl (R,E)-13-methyl-3,8-diphenyl-8,13-dihydro-7H-benzo[2,3]azocino[4,5-b]indole-6-carboxylate (3l): Yellow solid, 16.5 mg, 63% yield. ${[\alpha ]}_{\text{D}}^{\text{20}}$ -201.1 (c 1.1, acetone). m.p. 207~208 ℃; 1H NMR (400 MHz, CDCl3) δ: 7.77~7.68 (m, 4H), 7.52 (t, J=8.0 Hz, 2H), 7.45~7.38 (m, 2H), 7.36~7.29 (m, 2H), 7.26~7.17 (m, 5H), 7.16~7.09 (m, 1H), 7.05 (t, J=8.0 Hz, 1H), 5.39 (s, 1H), 5.04~4.96 (m, 1H), 3.59 (s, 3H), 3.27~3.18 (m, 1H), 2.92 (t, J=12.0 Hz, 1H), 2.08~1.96 (m, 2H), 1.95~1.67 (m, 6H); 13C NMR (100 MHz, CDCl3) δ: 164.1, 163.3, 148.2, 144.9, 140.1, 138.0, 137.9, 133.6, 130.4, 129.1, 128.7, 127.8, 127.3, 127.1, 126.6, 122.7, 122.6, 122.2, 119.7, 119.1, 115.9, 109.5, 79.4, 41.1, 38.8, 32.9, 32.6, 31.3, 24.0, 23.9; HRMS (ESI) calcd for C36H33N2O2 (M+H)+ 525.2537, found 525.2535. HPLC analysis: 93∶7 er [Daicel Chiralpak IA, hexane/i-PrOH, V∶V=60/40, 0.8 mL/min, λ=254 nm, tR(minor)=6.6 min, tR(major)=7.6 min]/
Cyclohexyl (R,E)-13-methyl-3,8-diphenyl-8,13-dihydro-7H-benzo[2,3]azocino[4,5-b]indole-6-carboxylate (3m): Yellow solid, 17.6 mg, 68% yield. ${[\alpha ]}_{\text{D}}^{\text{20}}$ -226.1 (c 0.6, acetone). m.p. 235~236 ℃; 1H NMR (400 MHz, CDCl3) δ: 7.77~7.66 (m, 4H), 7.51 (t, J=8.0 Hz, 2H), 7.44~7.36 (m, 2H), 7.32 (t, J=8.0 Hz, 2H), 7.26~7.16 (m, 5H), 7.15~7.08 (m, 1H), 7.04 (t, J=8.0 Hz, 1H), 5.07~4.94 (m, 2H), 3.58 (s, 3H), 3.30~3.21 (m, 1H), 2.92 (t, J=12.0 Hz, 1H), 1.98 (s, 2H), 1.82 (s, 2H), 1.70~1.34 (m, 6H); 13C NMR (100 MHz, CDCl3) δ: 164.0, 162.9, 148.9, 144.9, 137.7, 133.6, 132.0, 129.0, 128.6, 127.3, 127.0, 126.5, 125.1, 122.4, 122.0, 121.6, 119.5, 119.0, 115.7, 109.4, 75.1, 41.1, 38.7, 31.5, 31.5, 31.1, 25.4, 23.9; HRMS (ESI) calcd for C37H35N2O2 (M+H)+ 539.2693, found 539.2690. HPLC analysis: 95∶5 er [Daicel Chiralpak OD-H, hexane/i-PrOH, V∶V=70/30, 0.8 mL/min, λ=254 nm, tR(minor)=9.8 min, tR(major)=4.8 min].
Cyclopentyl (R,E)-8-(4-chlorophenyl)-13-methyl-3-phenyl-8,13-dihydro-7H-benzo[2,3]azocino[4,5-b]indole-6-carboxylate (3n): Yellow solid, 20.4 mg, 72% yield. ${[\alpha ]}_{\text{D}}^{\text{20}}$ -248.4 (c 0.6, acetone). m.p. 143~145 ℃; 1H NMR (400 MHz, CDCl3) δ: 7.80~7.65 (m, 4H), 7.50 (t, J=8.0 Hz, 2H), 7.42 (t, J=8.0 Hz, 1H), 7.36~7.29 (m, 3H), 7.25~7.22 (m, 1H), 7.19~7.08 (m, 4H), 7.05 (t, J=8.0 Hz, 1H), 5.43~5.31 (m, 1H), 5.01~4.91 (m, 1H), 3.58 (s, 3H), 3.25~3.11 (m, 1H), 2.84 (t, J=12.0 Hz, 1H), 2.09~1.65 (m, 8H); 13C NMR (100 MHz, CDCl3) δ: 163.6, 163.3, 148.0, 143.3, 139.9, 138.1, 137.8, 133.6, 132.2, 130.3, 129.1, 128.8, 128.6, 127.8, 127.0, 126.8, 126.4, 122.7, 121.9, 119.7, 118.8, 115.4, 109.5, 79.5, 40.5, 38.5, 32.8, 32.5, 31.3, 23.9, 23.9; HRMS (ESI) calcd for C36H32ClN2O2 (M+H)+ 559.2147, found 559.2143. HPLC analysis: 93∶7 er [Daicel Chiralpak OD-H, hexane/i-PrOH, V∶V=50∶50, 0.8 mL/min, λ=254 nm, tR(minor)=8.8 min, tR(major)=6.0 min].
Cyclopentyl (R,E)-8-(3-chlorophenyl)-13-methyl-3-phenyl-8,13-dihydro-7H-benzo[2,3]azocino[4,5-b]indole-6-carboxylate (3o): Yellow solid, 19.4 mg, 70% yield. ${[\alpha ]}_{\text{D}}^{\text{20}}$ -210.9 (c 0.9, acetone). m.p. 197~198 ℃; 1H NMR (400 MHz, CDCl3) δ: 7.78~7.68 (m, 4H), 7.51 (t, J=8.0 Hz, 2H), 7.44~7.36 (m, 2H), 7.33 (d, J=8.0 Hz, 2H), 7.27 (t, J=8.0 Hz, 1H), 7.20 (s, 1H), 7.17~7.04 (m, 4H), 5.45~5.34 (m, 1H), 5.05~4.92 (m, 1H), 3.58 (s, 3H), 3.28~3.15 (m, 1H), 2.88 (t, J=12.0 Hz, 1H), 2.04~1.65 (m, 8H); 13C NMR (100 MHz, CDCl3) δ: 163.6, 163.3, 148.0, 147.0, 139.9, 138.3, 137.8, 134.4, 133.7, 130.4, 130.0, 129.1, 127.9, 127.8, 127.5, 127.1, 126.8, 126.8, 125.5, 122.7, 122.7, 121.9, 119.8, 118.8, 115.2, 109.6, 79.5, 40.8, 38.6, 32.9, 32.6, 31.3, 24.0, 23.9; HRMS (ESI) calcd for C36H32- ClN2O2 (M+H)+ 559.2147, found 559.2145. HPLC analysis: 95∶5 er [Daicel Chiralpak OD-H, hexane/i-PrOH, V∶V=50∶50, 0.8 mL/min, λ=254 nm, tR(minor)=8.7 min, tR(major)=6.3 min].
Cyclopentyl (R,E)-8-(4-methoxyphenyl)-13-methyl-3-phenyl-8,13-dihydro-7H-benzo[2,3]azocino[4,5-b]indole-6-carboxylate (3p): Yellow solid, 11.6 mg, 42% yield. ${[\alpha ]}_{\text{D}}^{\text{20}}$ -72.4 (c 0.4, acetone). m.p. 113~115 ℃; 1H NMR (400 MHz, CDCl3) δ: 7.74~7.66 (m, 4H), 7.50 (t, J=8.0 Hz, 2H), 7.44~7.35 (m, 2H), 7.30 (d, J=8.0 Hz, 2H), 7.22 (t, J=8.0 Hz, 1H), 7.09 (d, J=8.0 Hz, 2H), 7.04 (t, J=8.0 Hz, 1H), 6.73 (d, J=8.0 Hz, 2H), 5.37 (s, 1H), 4.99~4.90 (m, 1H), 3.69 (s, 3H), 3.57 (s, 3H), 3.23~3.15 (m, 1H), 2.86 (t, J=12.0 Hz, 1H), 2.03~1.93 (m, 2H), 1.90~1.66 (m, 6H); 13C NMR (100 MHz, CDCl3) δ: 164.1, 163.4, 158.2, 148.1, 140.1, 138.0, 137.1, 130.4, 129.1, 128.2, 127.7, 127.0, 122.7, 122.6, 122.2, 119.6, 119.1, 116.3, 114.1, 109.5, 79.4, 55.3, 40.3, 38.9, 32.9, 32.6, 31.3, 24.0, 23.9; HRMS (ESI) calcd for C37H35N2O3 (M+H)+ 555.2642, found 555.2640. HPLC analysis: 86∶14 er [Daicel Chiralpak IA, hexane/i-PrOH, V∶V=60∶40, 0.7 mL/min, λ=254 nm, tR(minor)=7.3 min, tR(major)=8.5 min].
Isopropyl (R,E)-13-methyl-8-phenyl-3-(p-tolyl)-8,13-dihydro-7H-benzo[2,3]azocino[4,5-b]indole-6-carboxylate (3q): Yellow solid, 18.9 mg, 73% yield. ${[\alpha ]}_{\text{D}}^{\text{20}}$ -88.3 (c 0.7, acetone). m.p. 246~247 ℃; 1H NMR (400 MHz, CDCl3) δ: 7.75~7.70 (m, 2H), 7.60 (d, J=8.0 Hz, 2H), 7.40 (d, J=8.0 Hz, 1H), 7.32 (d, J=8.0 Hz, 4H), 7.26~7.18 (m, 5H), 7.12 (s, 1H), 7.05 (t, J=8.0 Hz, 1H), 5.32~5.19 (m, 1H), 5.07~4.94 (m, 1H), 3.59 (s, 3H), 3.32~3.23 (m, 1H), 2.92 (t, J=12.0 Hz, 1H), 2.45 (s, 3H), 1.44 (d, J=8.0 Hz, 3H), 1.40 (d, J=8.0 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ: 164.1, 163.2, 147.9, 144.9, 138.0, 137.9, 137.6, 133.7, 130.2, 129.9, 128.7, 127.5, 127.4, 127.1, 126.9, 126.6, 122.7, 122.6, 122.2, 119.6, 119.2, 115.9, 109.5, 70.3, 41.1, 38.7, 31.3, 21.9, 21.3; HRMS (ESI) calcd for C35H33N2O2 (M+H)+ 513.2537, found 513.2535. HPLC analysis: 95∶5 er [Daicel Chiralpak OD-H, hexane/i-PrOH, V∶V=50∶50, 0.8 mL/ min, λ=254 nm, tR(minor)=6.5 min, tR(major)=5.2 min].
Cyclopentyl (R,E)-13-methyl-8-phenyl-3-(p-tolyl)-8,13-dihydro-7H-benzo[2,3]azocino[4,5-b]indole-6-carboxylate (3r): Yellow solid, 17.9 mg, 69% yield. ${[\alpha ]}_{\text{D}}^{\text{20}}$ +130.0 (c 0.9, acetone). m.p. 264~265 ℃; 1H NMR (400 MHz, CDCl3) δ: 7.75~7.67 (m, 2H), 7.58 (d, J=8.0 Hz, 2H), 7.37 (d, J=8.0 Hz, 1H), 7.34~7.27 (m, 4H), 7.25~7.16 (m, 5H), 7.13~7.08 (m, 1H), 7.03 (t, J=8.0 Hz, 1H), 5.37 (s, 1H), 5.03~4.93 (m, 1H), 3.57 (s, 3H), 3.24~3.15 (m, 1H), 2.90 (t, J=12.0 Hz, 1H), 2.43 (s, 3H), 2.04~1.93 (m, 2H), 1.92~1.63 (m, 6H); 13C NMR (100 MHz, CDCl3) δ: 164.1, 163.4, 158.2, 148.1, 140.1, 138.0, 137.1, 130.4, 129.1, 128.2, 127.7, 127.0, 122.7, 122.6, 122.2, 119.6, 119.1, 116.3, 114.1, 109.5, 79.4, 55.3, 40.3, 38.9, 32.9, 32.6, 31.3, 24.0, 23.9; HRMS (ESI) calcd for C37H35N2O2 (M+H)+ 539.2693, found 539.2691. HPLC analysis: 97∶3 er [Daicel Chiralpak IA, hexane/i-PrOH, V∶V=60∶40, 0.7 mL/min, λ=254 nm, tR(minor)=9.1 min, tR(major)=11.6 min].
Cyclohexyl (R,E)-13-methyl-8-phenyl-3-(p-tolyl)-8,13-dihydro-7H-benzo[2,3]azocino[4,5-b]indole-6-carboxylate (3s): Yellow solid, 18.5 mg, 67% yield. ${[\alpha ]}_{\text{D}}^{\text{20}}$ -164.2 (c 0.7, acetone). m.p. 176~177 ℃; 1H NMR (400 MHz, CDCl3) δ: 7.76~7.69 (m, 2H), 7.60 (d, J=8.0 Hz, 2H), 7.39 (d, J=8.0 Hz, 1H), 7.32 (d, J=8.0 Hz, 4H), 7.26~7.17 (m, 5H), 7.15~7.08 (m, 1H), 7.05 (t, J=8.0 Hz, 1H), 5.09~4.95 (m, 2H), 3.58 (s, 3H), 3.31~3.20 (m, 1H), 2.93 (t, J=12.0 Hz, 1H), 2.45 (s, 3H), 2.04~1.91 (m, 2H), 1.89~1.78 (m, 2H), 1.71~1.35 (m, 6H); 13C NMR (100 MHz, CDCl3) δ: 164.1, 162.9, 147.9, 145.0, 138.0, 137.9, 137.6, 137.2, 133.7, 130.2, 129.8, 128.7, 127.5, 127.3, 127.1, 126.9, 126.6, 122.7, 122.6, 122.2, 119.6, 119.1, 115.9, 109.5, 75.1, 41.1, 38.8, 31.6, 31.6, 31.3, 25.4, 23.9, 21.3; HRMS (ESI) calcd for C38H37N2O2 (M+H)+ 553.2850, found 553.2857. HPLC analysis: 98∶2 er [Daicel Chiralpak IA, hexane/i-PrOH, V∶V=60∶40, 0.7 mL/min, λ=254 nm, tR(minor)=11.9 min, tR(major)=17.0 min].
Cyclopentyl (R,E)-13-methyl-3,8-di-p-tolyl-8,13-dihydro-7H-benzo[2,3]azocino[4,5-b]indole-6-carboxylate (3t): Yellow solid, 14.9 mg, 54% yield. ${[\alpha ]}_{\text{D}}^{\text{20}}$ -88.9 (c 1.1, acetone). m.p. 251~252 ℃; 1H NMR (400 MHz, CDCl3) δ: 7.70 (d, J=7.2 Hz, 2H), 7.59 (d, J=8.0 Hz, 2H), 7.39 (d, J=8.0 Hz, 1H), 7.34~7.28 (m, 4H), 7.24 (t, J=8.0 Hz, 1H), 7.10~6.99 (m, 5H), 5.38 (s, 1H), 5.01~4.93 (m, 1H), 3.57 (s, 3H), 3.24~3.16 (m, 1H), 2.89 (t, J=12.0 Hz, 1H), 2.44 (s, 3H), 2.23 (s, 3H), 2.05~1.95 (m, 2H), 1.93~1.68 (m, 6H); 13C NMR (100 MHz, CDCl3) δ: 164.1, 163.4, 147.9, 141.9, 138.0, 137.9, 137.6, 137.2, 136.1, 133.6, 130.2, 129.8, 129.4, 127.5, 127.2, 127.1, 126.9, 122.6, 122.5, 122.2, 119.6, 119.1, 116.1, 109.5, 79.4, 40.7, 38.8, 32.9, 32.6, 31.3, 24.0, 23.9, 21.3, 21.1; HRMS (ESI) calcd for C38H37N2O2 (M+H)+ 553.2850, found 553.2848. HPLC analysis: 85∶15 er [Daicel Chiralpak IA, hexane/ i-PrOH, V∶V=60∶40, 1 mL/min, λ=254 nm, tR(minor)=6.3 min, tR(major)=7.9 min].
Cyclopentyl (R,E)-8-(4-methoxyphenyl)-13-methyl-3-(p-tolyl)-8,13-dihydro-7H-benzo[2,3]azocino[4,5-b]indole-6-carboxylate (3u): Yellow solid, 11.6 mg, 47% yield. ${[\alpha ]}_{\text{D}}^{\text{20}}$ -116.5 (c 0.9, acetone). m.p. 155~156 ℃; 1H NMR (400 MHz, CDCl3) δ: 7.74~7.69 (m, 2H), 7.60 (d, J=8.0 Hz, 2H), 7.39 (d, J=8.0 Hz, 1H), 7.32 (d, J=8.0 Hz, 4H), 7.24 (t, J=8.0 Hz, 1H), 7.11 (d, J=8.0 Hz, 2H), 7.05 (t, J=8.0 Hz, 1H), 6.74 (d, J=8.0 Hz, 2H), 5.43~5.35 (m, 1H), 5.01~4.90 (m, 1H), 3.71 (s, 3H), 3.58 (s, 3H), 3.20 (t, J=12.0, 8.0 Hz, 1H), 2.88 (t, J=12.0 Hz, 1H), 2.44 (s, 3H), 2.05~1.95 (m, 2H), 1.94~1.66 (m, 6H); 13C NMR (100 MHz, CDCl3) δ: 164.1, 163.4, 158.2, 147.9, 137.9, 137.9, 137.6, 137.2, 137.1, 133.5, 130.2, 129.8, 128.2, 127.5, 127.1, 126.9, 122.7, 122.6, 122.2, 119.6, 119.1, 116.2, 114.1, 109.5, 79.4, 55.3, 40.3, 38.9, 32.9, 32.6, 31.3, 24.0, 23.9, 21.3, 14.2; HRMS (ESI) calcd for C38H37N2O3 (M+H)+ 569.2799, found 569.2798. HPLC analysis: 88∶12 er [Daicel Chiralpak IA, hexane/i-PrOH, V∶V=60∶40, 0.8 mL/min, λ=254 nm, tR(minor)=10.0 min, tR(major)=12.1 min].
Cyclopentyl (R,E)-8-(4-chlorophenyl)-13-methyl-3-(p-tolyl)-8,13-dihydro-7H-benzo[2,3]azocino[4,5-b]indole-6- carboxylate (3v): Yellow solid, 16.6 mg, 59% yield. ${[\alpha ]}_{\text{D}}^{\text{20}}$ -119.2 (c 0.8, acetone). m.p. 176~177 ℃; 1H NMR (400 MHz, CDCl3) δ: 7.73~7.68 (m, 2H), 7.58 (d, J=8.0 Hz, 2H), 7.36~7.29 (m, 5H), 7.26~7.22 (m, 1H), 7.19~7.10 (m, 4H), 7.05 (t, J=8.0 Hz, 1H), 5.41~5.33 (m, 1H), 5.00~4.92 (m, 1H), 3.57 (s, 3H), 3.22~3.15 (m, 1H), 2.85 (t, J=12.0 Hz, 1H), 2.44 (s, 3H), 2.04~1.94 (m, 2H), 1.90~1.66 (m, 6H).;13C NMR (100 MHz, CDCl3) δ: 163.6, 163.4, 147.8, 143.4, 138.1, 137.9, 137.7, 137.1, 133.7, 132.3, 130.1, 129.9, 128.9, 128.7, 127.6, 126.9, 122.7, 121.9, 119.8, 118.9, 115.4, 109.6, 79.5, 40.5, 38.6, 32.9, 32.6, 31.3, 24.0, 23.9, 21.3; HRMS (ESI) calcd for C37H34ClN2O2 (M+H)+ 573.2303, found 573.2300. HPLC analysis: 95∶5 er [Daicel Chiralpak OD-H, hexane/i-PrOH, V∶V=50/50, 0.8 mL/min, λ=254 nm, tR(minor)=8.0 min, tR(major)=5.9 min].
Cyclopentyl (R,E)-8-(3-chlorophenyl)-13-methyl-3-(p-tolyl)-8,13-dihydro-7H-benzo[2,3]azocino[4,5-b]indole-6- carboxylate (3w): Yellow solid, 19.8 mg, 68% yield. ${[\alpha ]}_{\text{D}}^{\text{20}}$ -276.6 (c 1.0, acetone). m.p. 259~260 ℃; 1H NMR (400 MHz, CDCl3) δ: 7.73~7.69 (m, 2H), 7.59 (d, J=8.0 Hz, 2H), 7.37 (d, J=8.0 Hz, 1H), 7.34~7.28 (m, 4H), 7.26~7.21 (m, 1H), 7.18 (s, 1H), 7.14~7.04 (m, 4H), 5.40~5.32 (m, 1H), 5.00~4.91 (m, 1H), 3.56 (s, 3H), 3.26~3.14 (m, 1H), 2.86 (t, J=12.0 Hz, 1H), 2.43 (s, 3H), 2.05~1.95 (m, 2H), 1.90~1.66 (m, 6H); 13C NMR (100 MHz, CDCl3) δ: 163.6, 163.3, 147.8, 147.0, 138.3, 137.7, 137.1, 134.4, 133.8, 130.2, 130.0, 129.8, 127.7, 127.6, 126.9, 126.8, 125.5, 122.7, 122.7, 121.9, 119.8, 118.8, 115.2, 109.6, 79.5, 40.9, 38.6, 32.9, 32.6, 31.3, 24.0, 23.9, 21.3; HRMS (ESI) calcd for C37H34ClN2O2 (M+H)+ 573.2303, found 573.2301. HPLC analysis: 91∶9 er [Daicel Chiralpak IA, hexane/i-PrOH, V∶V=60∶40, 0.8 mL/min, λ=254 nm, tR(minor)=6.5 min, tR(major)=8.2 min].
Cyclopentyl (R,E)-8-(4-bromophenyl)-13-methyl-3-(p-tolyl)-8,13-dihydro-7H-benzo[2,3]azocino[4,5-b]indole-6-carboxylate (3x): Yellow solid, 18.8 mg, 61% yield. ${[\alpha ]}_{\text{D}}^{\text{20}}$ -105.5 (c 0.2, acetone). m.p. 157~158 ℃; 1H NMR (400 MHz, CDCl3) δ: 7.74~7.68 (m, 2H), 7.57 (d, J=8.0 Hz, 2H), 7.36~7.28 (m, 7H), 7.26~7.21 (m, 1H), 7.06 (d, J=8.0 Hz, 3H), 5.40~5.33 (m, 1H), 4.99~4.91 (m, 1H), 3.57 (s, 3H), 3.52~3.47 (m, 1H), 3.23~3.14 (m, 1H), 2.85 (t, J=12.0 Hz, 1H), 2.44 (s, 3H), 2.05~1.94 (m, 2H), 1.92~1.64 (m, 6H); 13C NMR (100 MHz, CDCl3) δ: 163.6, 163.4, 147.8, 143.9, 138.1, 137.9, 137.7, 137.0, 133.7, 131.8, 130.1, 129.9, 129.1, 127.7, 126.9, 122.7, 121.9, 120.3, 119.8, 118.9, 115.3, 109.6, 79.5, 66.0, 40.6, 38.5, 32.9, 32.6, 31.3, 24.0, 23.9, 21.3, 15.4; HRMS (ESI) calcd for C37H34BrN2O2 (M+H)+ 617.1798, found 617.1796. HPLC analysis: 90∶10 er [Daicel Chiralpak IA, hexane/i-PrOH, V∶V=60∶40, 1 mL/min, λ=254 nm, tR(minor)=8.3 min, tR(major)=10.7 min].
Methyl (R,E)-13-methyl-8-phenyl-8,13-dihydro-7H-benzo[2,3]azocino[4,5-b]indole-6-carboxylate (3y): Yellow solid, 14.4 mg, 73% yield. ${[\alpha ]}_{\text{D}}^{\text{20}}$ -88.2 (c 2.2, CHCl3). m.p. 137~138 ℃; 1H NMR (400 MHz, CDCl3) δ: 7.49 (t, J=8.0 Hz, 2H), 7.39 (d, J=8.0 Hz, 2H), 7.29 (d, J=8.0 Hz, 1H), 7.25~7.17 (m, 6H), 7.14~7.08 (m, 1H), 7.04 (t, J=8.0 Hz, 1H), 5.01~4.90 (m, 1H), 3.89 (s, 3H), 3.50 (s, 3H), 3.33~3.25 (m, 1H), 2.81 (t, J=12.0 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ: 164.2, 163.5, 148.6, 144.8, 137.8, 133.5, 132.1, 129.1, 128.7, 127.3, 127.0, 126.6, 125.4, 122.6, 121.9, 121.7, 119.6, 119.2, 115.9, 109.4, 53.3, 40.8, 38.3, 31.1, 27.0; HRMS (ESI) calcd for C26H23N2O2 (M+H)+ 395.1754, found 395.1752. HPLC analysis: 80∶20 er [Daicel Chiralpak OD-H, hexane/i-PrOH, V∶V=70∶30, 1 mL/min, λ=254 nm, tR(minor)=7.0 min, tR(major)=6.5 min].